Market Updates

Forbes Medi-Tech, Fayrefield Sign Agreement

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

After Forbes Medi-Tech, Vancouver, British Columbia, Canada, received final approval for Reducol sales in the European Union (EU) last year, the company signed a five-year sales and licensing agreement with Fayrefield Foods, Crewe, U.K., to supply Re­ducol for use in milk-based drinks. Applications for other food groups are expected to be filed before year-end. Development teams from both Forbes Medi-Tech and Fayrefield are preparing for a product launch in the first half of 2005. Forbes will announce the specific brand name as soon as it is launched in the market.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters